American Trust’s Silicon Laboratories SLAB Stock Holding History

American Trust’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-992	Closed	-$205K	–	531
2021 Q4	$205K	Buy	+992	New	+$183K	0.02%	346

Other funds holding SLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

American Trust's SLAB Position: Q1 2022 in Review

American Trust sold out of Silicon Laboratories (SLAB) in Q1 2022, closing a stake of 992 shares — an estimated $205K sold.

American Trust first reported a position in SLAB in Q4 2021 and held it in 1 quarter. The position peaked at $205K in Q4 2021. 327 funds tracked by Wall St. Rank hold SLAB as of Q1 2022.

American Trust reported no remaining Silicon Laboratories position as of Q1 2022 after selling out during the quarter.
American Trust sold 992 Silicon Laboratories shares in Q1 2022, an estimated $205K.
American Trust first reported a position in Silicon Laboratories in Q4 2021 and held it in 1 quarter.
American Trust's Silicon Laboratories position peaked at $205K in Q4 2021.
327 funds tracked by Wall St. Rank held Silicon Laboratories as of Q1 2022.

Based on American Trust's 13F filing for Q1 2022, filed 8 Jun 2022.